Literature DB >> 20549580

T cell acute lymphoblastic leukemia arising from familial platelet disorder.

Nahoko Nishimoto1, Yoichi Imai, Koki Ueda, Masahiro Nakagawa, Akihito Shinohara, Motoshi Ichikawa, Yasuhito Nannya, Mineo Kurokawa.   

Abstract

Familial platelet disorder (FPD) is a rare autosomal dominant disorder which causes moderate thrombocytopenia with or without impaired platelet function. Patients have a propensity to develop acute myeloid leukemia (AML), and various types of second hits have been postulated in the evolution to AML. However, only a few cases of acute lymphoblastic leukemia (ALL) have been reported thus far. Here, we report a family of FPD with a germ-line hemi-allelic mutation R174X in the RUNX1 gene. The proband of the family developed AML and her son had ALL of the T cell lineage. The balanced translocation t(1;7)(p34.1;q22) was detected in the lymphoblasts from the patient with ALL. This translocation was not seen in any other affected members of the family or in the bone marrow sample of this patient in complete remission. Taken together, t(1;7)(p34.1;q22) is thought to be one of the somatic second hits that predisposes FPD to acute leukemia with T cell phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549580     DOI: 10.1007/s12185-010-0612-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  10 in total

1.  Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2.

Authors:  C Y Ho; B Otterud; R D Legare; T Varvil; R Saxena; D B DeHart; S E Kohler; J C Aster; S B Dowton; F P Li; M Leppert; D G Gilliland
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

2.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.

Authors:  W J Song; M G Sullivan; R D Legare; S Hutchings; X Tan; D Kufrin; J Ratajczak; I C Resende; C Haworth; R Hock; M Loh; C Felix; D C Roy; L Busque; D Kurnit; C Willman; A M Gewirtz; N A Speck; J H Bushweller; F P Li; K Gardiner; M Poncz; J M Maris; D G Gilliland
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

3.  Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma.

Authors:  Mondira Kundu; Sheila Compton; Lisa Garrett-Beal; Terryl Stacy; Matthew F Starost; Michael Eckhaus; Nancy A Speck; P Paul Liu
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

4.  High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.

Authors:  Claude Preudhomme; Aline Renneville; Violaine Bourdon; Nathalie Philippe; Catherine Roche-Lestienne; Nicolas Boissel; Nathalie Dhedin; Jean-Marie André; Pascale Cornillet-Lefebvre; André Baruchel; Marie-Joelle Mozziconacci; Hagay Sobol
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

5.  Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.

Authors:  Antonella Minelli; Emanuela Maserati; Gabriele Rossi; Maria Ester Bernardo; Piero De Stefano; Maria Paola Cecchini; Roberto Valli; Veronica Albano; Paolo Pierani; Anna Leszl; Laura Sainati; Francesco Lo Curto; Cesare Danesino; Franco Locatelli; Francesco Pasquali
Journal:  Genes Chromosomes Cancer       Date:  2004-07       Impact factor: 5.006

6.  Studies of a familial platelet disorder.

Authors:  S B Dowton; D Beardsley; D Jamison; S Blattner; F P Li
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

7.  AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.

Authors:  Motoshi Ichikawa; Takashi Asai; Toshiki Saito; Sachiko Seo; Ieharu Yamazaki; Tetsuya Yamagata; Kinuko Mitani; Shigeru Chiba; Seishi Ogawa; Mineo Kurokawa; Hisamaru Hirai
Journal:  Nat Med       Date:  2004-02-15       Impact factor: 53.440

8.  Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.

Authors:  Masakazu Higuchi; Darin O'Brien; Parasakthy Kumaravelu; Noel Lenny; Eng-Juh Yeoh; James R Downing
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

9.  Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.

Authors:  Carolyn J Owen; Cynthia L Toze; Anna Koochin; Donna L Forrest; Clayton A Smith; Jane M Stevens; Shannon C Jackson; Man-Chiu Poon; Gary D Sinclair; Brian Leber; Peter R E Johnson; Anthony Macheta; John A L Yin; Michael J Barnett; T Andrew Lister; Jude Fitzgibbon
Journal:  Blood       Date:  2008-08-21       Impact factor: 22.113

10.  Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors.

Authors:  Weili Sun; James R Downing
Journal:  Blood       Date:  2004-08-05       Impact factor: 22.113

  10 in total
  19 in total

Review 1.  Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia.

Authors:  Yoshihiro Gocho; Jun J Yang
Journal:  Blood       Date:  2019-07-16       Impact factor: 22.113

Review 2.  Role of RUNX1 in hematological malignancies.

Authors:  Raman Sood; Yasuhiko Kamikubo; Paul Liu
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 3.  Myeloid neoplasms with germ line RUNX1 mutation.

Authors:  Yoshihiro Hayashi; Yuka Harada; Gang Huang; Hironori Harada
Journal:  Int J Hematol       Date:  2017-05-22       Impact factor: 2.490

Review 4.  Familial myelodysplastic syndromes: a review of the literature.

Authors:  Elena Liew; Carolyn Owen
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

5.  Genetic loss of SH2B3 in acute lymphoblastic leukemia.

Authors:  Arianne Perez-Garcia; Alberto Ambesi-Impiombato; Michael Hadler; Isaura Rigo; Charles A LeDuc; Kara Kelly; Chaim Jalas; Elisabeth Paietta; Janis Racevskis; Jacob M Rowe; Martin S Tallman; Maddalena Paganin; Giuseppe Basso; Wei Tong; Wendy K Chung; Adolfo A Ferrando
Journal:  Blood       Date:  2013-08-01       Impact factor: 22.113

Review 6.  Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).

Authors:  Anna L Brown; Christopher N Hahn; Hamish S Scott
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

Review 7.  Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.

Authors:  Allison H West; Lucy A Godley; Jane E Churpek
Journal:  Ann N Y Acad Sci       Date:  2014-01-27       Impact factor: 5.691

Review 8.  A role for RUNX1 in hematopoiesis and myeloid leukemia.

Authors:  Motoshi Ichikawa; Akihide Yoshimi; Masahiro Nakagawa; Nahoko Nishimoto; Naoko Watanabe-Okochi; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2013-04-24       Impact factor: 2.490

9.  Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.

Authors:  Chi Young Ok; Vasiliki Leventaki; Sa A Wang; Courtney Dinardo; L Jeffrey Medeiros; Sergej Konoplev
Journal:  Am J Clin Pathol       Date:  2016-01-22       Impact factor: 2.493

Review 10.  The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.

Authors:  Francesca Gianni; Laura Belver; Adolfo Ferrando
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.